Related Experiment Video
Updated: Oct 4, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial
Takayuki Honda1, Hiroyuki Sakashita1, Kyohei Masai1
1Takayuki Honda, Kouya Shiraishi, Yoko Shimada, Ayaka Otsuka, and Takashi Kohno, National Cancer Center Research Institute, Chuo-ku; Takayuki Honda, Hiroyuki Sakashita, Masashi Kobayashi, Takumi Akashi, Kenichi Okubo, and Naohiko Inase, Tokyo Medical and Dental University, Bunkyo-ku; Kyohei Masai, Noriko Motoi, and Shun-ichi Watanabe, National Cancer Center Hospital, Chuo-ku; Kyohei Masai and Yae Kanai, Keio University School of Medicine, Sinjuku-ku; Hirohiko Totsuka, StaGen, Taito-ku; Suenori Chiku, Mizuho Information and Research Institute, Chiyoda-ku, Tokyo; Sachiyo Mimaki and Katsuya Tsuchihara, EPOC, National Cancer Center, Kashiwa, Chiba; and Koji Tsuta, Kansai Medical University, Hirakata, Osaka, Japan.
Purpose:
Usual interstitial pneumonia (UIP) is a risk factor for lung carcinogenesis. This study was performed to characterize mutagenesis and mutational target genes underlying lung carcinogenesis in patients with UIP.
Patients And Methods:
A cohort of 691 Japanese patients with lung adenocarcinoma (LADC), of whom 54 had UIP and 637 did not, was studied for driver oncogene aberrations. Whole-exome analysis was performed for 296 cases, including 51 with UIP, to deduce mutagenic processes and identify commonly affected genes. Logistic regression analysis was used to detect associations of gene aberrations with clinicopathological factors.
Results:
The EGFR mutation was markedly less prevalent in patients with LADC with UIP than in those without (1.9% [one of 54] v. 49.9% [318 of 637]; P < .001), even in heavy smokers (25.3% [38 of 150] of patients with > 40 pack-years; P < .001). Mutational signature analysis indicated that UIP-positive LADCs develop through accumulation of single-nucleotide and indel mutations caused by smoking. Pulmonary surfactant system genes (PSSGs) NKX2-1/TTF1, SFTPA1, SFTPA2, SFTPB, and SFTPC were identified as targets for mutations (preferentially indels), and mutations were specifically associated with shorter overall survival of patients with UIP-positive LADC, independent of pathologic stage (hazard ratio, 4.9; 95% CI, 1.7 to 14.4; P = .0037).
Conclusion:
LADCs with UIP develop through mutational events caused by smoking, independently of EGFR mutation. PSSGs were identified as a mutational target and as a novel prognostic factor in UIP-positive LADC. PSSG deficiency might increase the malignancy of tumor cells by increasing the tumor-promoting effects of UIP.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Abnormal Proliferation
Breathing
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

